Key points are not available for this paper at this time.
Design
Editorial
Discusses the role of circulating cardiac troponin concentrations as a biomarker for myocardial injury beyond ischemia.
Circulating cardiac troponin (cTn) concentrations have become an increasingly important biomarker for the noninvasive detection of myocardial injury in many cardiovascular diseases, in particular, patients with coronary heart disease presenting with acute chest pain (1).
No takes yet. Share an insight, caveat, or question.
Li et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: